Expertise in
17
conditions

Dr. Elizabeth M. Berry-Kravis

Pediatric Neurology
Rush University Medical Center
1725 W Harrison St Ste 710, 
Chicago, IL 
Accepting New Patients
Offers Telehealth
Expertise in
17
conditions
Rush University Medical Center
1725 W Harrison St Ste 710, 
Chicago, IL 

Overview

Elizabeth Berry-Kravis is a Pediatric Neurologist practicing medicine in Chicago, Illinois.

Dr. Berry-Kravis is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Fragile X Syndrome, Autism Spectrum Disorder, Rett Syndrome, and Angelman Syndrome.

She is actively involved in clinical research, co-authoring 281 peer reviewed articles and participating in 10 clinical trials. Dr. Berry-Kravis is currently accepting new patients.

Specialties

Pediatric Neurology

Licenses

Pediatrics in IL

Hospital Affiliations

Rush University Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Icare Independent Care Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
SelectHealth
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Rush University Medical Center
1725 W Harrison St Ste 710, Chicago, IL 60612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children, Adolescents and Young Adults With Fragile X Syndrome - RECONNECT
Enrollment Status: Completed
Publish Date: September 01, 2026
Intervention Type: Drug
Study Drug: ZYN002
Study Phase: Phase 3
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Mapping the Genotype, Phenotype, and Natural History of Phelan-McDermid Syndrome
Enrollment Status: Active_not_recruiting
Publish Date: August 06, 2026
Cerliponase Alfa Observational Study
Cerliponase Alfa Observational Study
Enrollment Status: Active_not_recruiting
Publish Date: June 30, 2026
Intervention Type: Drug, Device
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Mapping the Phenotype in Adults With Phelan-McDermid Syndrome
Enrollment Status: Completed
Publish Date: February 18, 2025
Intervention Type: Other
A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome
A Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: December 19, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Assess the Safety, Tolerability and Efficacy of Oral Ketamine for Patients With Rett Syndrome
Enrollment Status: Completed
Publish Date: May 28, 2024
Intervention Type: Drug
Study Drug: Ketamine
Study Phase: Phase 2
A Phase 2, Placebo-controlled, Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) and Possible Other Treatments in Adolescent and Adult Males With Fragile X Syndrome (FXS)
A Phase 2, Placebo-controlled, Adaptive Design Study to Explore the Safety and Efficacy of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) and Possible Other Treatments in Adolescent and Adult Males With Fragile X Syndrome (FXS)
Enrollment Status: Withdrawn
Publish Date: December 08, 2022
Intervention Type: Drug
Study Drugs: Sulindac, Gaboxadol
Study Phase: Phase 2
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Rett Syndrome, MECP2 Duplication Disorder, and Rett- Related Disorders Natural History Protocol
Enrollment Status: Completed
Publish Date: August 05, 2021
Biobanking of Rett Syndrome and Related Disorders Protocol
Biobanking of Rett Syndrome and Related Disorders Protocol
Enrollment Status: Completed
Publish Date: August 05, 2021
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Double-Blind, Placebo-Controlled Proof of Concept Study in Youth With Fragile X Syndrome
Enrollment Status: Completed
Publish Date: February 03, 2021
Intervention Type: Drug
Study Phase: Phase 1
View 9 Less Clinical Trials

281 Total Publications

Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.
Electroencephalographic Transient Beta Event Rates in Autism and Related Neurogenetic Conditions.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Similar Doctors
Expertise in
9
conditions
Dr. James H. Tonsgard
Pediatric Neurology | Neurology
Expertise in
9
conditions
Dr. James H. Tonsgard
Pediatric Neurology | Neurology
Referral may be required

Comer Children's Hospital - Hyde Park

5721 S. Maryland Ave., 
Chicago, IL 
 (7.5 miles away)
888-824-0200
Languages Spoken:
English, Italian
See accepted insurances
Accepting New Patients
Offers Telehealth

James Tonsgard is a Pediatric Neurologist and a Neurologist practicing medicine in Chicago, Illinois. Dr. Tonsgard is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Neurofibromatosis Type 1 (NF1), Neurofibromatosis Type 2 (NF2), and RASopathies. Dr. Tonsgard is board certified in Pediatrics and Practicing Since1978. Dr. Tonsgard is currently accepting new patients.

Expertise in
13
conditions
Dr. Douglas R. Nordli
Pediatric Neurology
Expertise in
13
conditions
Dr. Douglas R. Nordli
Pediatric Neurology
Referral may be required

Comer Children's Hospital

5721 S Maryland Ave, 
Chicago, IL 
 (7.5 miles away)
773-702-6169
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Douglas Nordli is a Pediatric Neurologist practicing medicine in Chicago, Illinois. Dr. Nordli is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Epilepsy, Seizures, and Epilepsy in Children. Dr. Nordli is currently accepting new patients.

Expertise in
4
conditions
Dr. Peter T. Heydemann
Pediatric Neurology
Expertise in
4
conditions
Dr. Peter T. Heydemann
Pediatric Neurology
Referral may be required

Office

1725 W Harrison St Ste 718, 
Chicago, IL 
 (0.1 miles away)
312-942-4036
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Peter Heydemann is a Pediatric Neurologist practicing medicine in Chicago, Illinois. Dr. Heydemann is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Rett Syndrome, Congenital Toxoplasmosis, Duchenne Muscular Dystrophy, and Seizures. Dr. Heydemann is currently accepting new patients in some locations.

Frequently Asked Questions about Dr. Elizabeth M. Berry-Kravis

How do I make an appointment with Dr. Elizabeth M. Berry-Kravis?

You can book an appointment with Dr. Elizabeth M. Berry-Kravis by calling their office at 312-942-4036. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Elizabeth M. Berry-Kravis a top-rated expert for Fragile X Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Elizabeth M. Berry-Kravis is classified as an Elite expert for Fragile X Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Elizabeth M. Berry-Kravis specialize in?

While Dr. Elizabeth M. Berry-Kravis is a Pediatric Neurology, they have specific expertise in Fragile X Syndrome, Autism Spectrum Disorder, and Rett Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Neurology.

Does Dr. Elizabeth M. Berry-Kravis participate in research or clinical trials?

Yes. Dr. Elizabeth M. Berry-Kravis has published 281 articles and abstracts on conditions like Fragile X Syndrome. You can view a list of Dr. Elizabeth M. Berry-Kravis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Elizabeth M. Berry-Kravis accept my insurance?

Dr. Elizabeth M. Berry-Kravis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 312-942-4036 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Berry-Kravis's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 23 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile